FREE patent keyword monitoring and additional FREE benefits. http://images1.freshpatents.com/images/triangleright (1K) REGISTER now for FREE triangleleft (1K)
FreshPatents.com Logo FreshPatents.com icons
Monitor Keywords Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents

Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |

Glaxosmithkline Corporate Intellectual Property-uw2220 patents

The following is a sampling of recent Glaxosmithkline Corporate Intellectual Property-uw2220 patent applications (USPTO Patent Application #, Patent Title) sorted by month.

April 2010 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20100093766 - Novel compounds

February 2010 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20100029699 - Matrix metalloproteinase inhibitors

January 2010 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20100010021 - Novel compounds

July 2009 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20090176973 - Thrombopoietin mimetics

October 2007 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20070244181 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
20070238752 - Muscarinic acetylcholine receptor antagonists

August 2007 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20070185153 - Compounds

July 2007 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20070161647 - Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists

November 2006 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20060263425 - Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent

September 2006 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20060205735 - Quinoline-4-carboxamide as nk-2 and nk-3 receptor antagonists

July 2006 - Glaxosmithkline Corporate Intellectual Property-uw2220 patents

20060160846 - Quinoline derivatives



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxosmithkline Corporate Intellectual Property-uw2220 in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxosmithkline Corporate Intellectual Property-uw2220 with additional patents listed. Browse our Agent directory for other possible listings.

###

Design/code © 2013 FreshContext LLC/Freshpatents.com.
Patent data source: patents published by the United States Patent and Trademark Office (USPTO)
Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and may contain additional data/images. FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents and there may be applicable trademarks or servicemarks within the documents.
FreshPatents.com Support - Terms & Conditions